Mary Guckian
King's College London(GB)King's College Hospital NHS Foundation Trust(GB)Kings Health Partners(GB)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Multiple Myeloma Research and Treatments, Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine(2021)322 cited
- CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production.(1998)
- → Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRαβ+ T cells(2011)98 cited
- → CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-α Production(1998)86 cited
- → Allogeneic whole‐cell vaccine: a phase I/II study in men with hormone‐refractory prostate cancer(2002)72 cited
- → Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection(2021)71 cited
- → Abnormal intracellular IL-2 and interferon-gamma (IFN-γ) production as HIV-1-associated markers of immune dysfunction